This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Subscribe To Our Newsletter & Stay Updated
